Home / Sweden / Hansa Biopharma AB

Hansa Biopharma AB

Short position disclosed on September 9, 2026.

Follow

1.50% of the capital sold short
2 disclosing funds
431 disclosures on record
SE0002148817 ISIN code

Evolution of the disclosed total

Open positions

In the United States HNSBF (OTC): 62,228 shares sold short on August 31, 2026. FINRA names no fund.

On the other side: the funds that hold Hansa Biopharma AB Titelia

History of disclosures

Download 431 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats

Other companies sold short in Sweden

• Samhällsbyggnadsbolaget i Norden AB 11.99% of the capital sold short
• Elekta AB (publ) 8.91% of the capital sold short
• JM AB 7.61% of the capital sold short
• Bonesupport Holding AB 6.69% of the capital sold short
• Truecaller AB 6.64% of the capital sold short
• Hemnet Group AB (publ) 6.13% of the capital sold short
• Xvivo Perfusion Aktiebolag 5.41% of the capital sold short
• Dynavox Group AB 4.58% of the capital sold short
• RaySearch Laboratories AB (publ) 4.36% of the capital sold short
• Aktiebolaget Electrolux 4.32% of the capital sold short
• AAK AB (publ) 4.23% of the capital sold short
• Tobii AB 3.54% of the capital sold short